THP-1 cells, a cell line derived from a patient with monocytic leukemia, were a reasonable candidate given their origins in the myeloid lineage and known production of CCL22 in response to a variety of stimuli (9, 10). The gene discussed is CCL22; the disease is monocytic leukemia.